News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Imágenes: captainvector/Adobe Stock; Alex/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/20102802/p-1-91495430-heres-every-cool-tech-thing-the-ai-ram-crunch-is-ruining.webp)
![[Foto: Pascal Le Segretain/Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/20105240/James-Cameron-Netflix-Fast-Company-Mexico-Cortesia.webp)
![[Imagen: NCPC]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/20090827/jardin-la-Casa-Blanca-Fast-Company-Mexico-Cortesia.webp)
![[Foto: Guven Yilmaz/Anadolu via Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/19085359/p-1-91494326-openclaw-peter-steinberger-openai-meta-lex-fridman.webp)
